Norwegian gene committee to be formed:
This article was originally published in Clinica
The central board of the Norwegian doctors' association is to set up a committee to evaluate ethics connected with the development of medical technology. The committee will advise the central board on aspects of gene and biotechnology and will be responsible for producing documentation that will form the basis of the association's policy. The committee will initially be formed after consultation with the various interested parties within the doctors' association, but it will then have access to exterior advice and expertise.
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.